• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Erythrocin Lactobionate Lyophilized Powder for Injection

 Status: Currently in Shortage

 » Date first reported: 04/21/2014
 » Therapeutic Categories: Anti-Infective; Pediatric

Hospira, Inc. (Revised 10/09/2014)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg Add-Vantage Vial (NDC 0409-6476-44) Next delivery October 2014; Estimated recovery 1Q 2015. Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay. Other
500 mg Vial (NDC 0409-6482-01) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available. Other
-
-